Category : Search result: pharmaceutical manufacturing


TSX climbs as tech and energy sectors boost markets

Canada's S&P/TSX composite gained strength from technology and energy sectors while U.S. markets showed mixed results. Manufacturing sales surged 3.3% in September, reaching highest level since February.

Why Manufacturing Tax Incentives Don't Work in Canada

Economist Jack Mintz argues Canada's 50-year experiment with manufacturing tax preferences has failed. True economic growth requires market-driven productivity improvements, not government favoritism.

Manufacturers Discuss Tariffs at Simcoe County Forum

Simcoe County manufacturers gathered at Nottawasaga Inn to address economic challenges including tariffs and market uncertainty. Key industry leaders shared insights on navigating today's complex business landscape.

SAAB could bring 10,000 jobs to Canada

Swedish defense manufacturer SAAB announces potential creation of 10,000 jobs in Canada, marking significant economic boost for Canadian defense sector and manufacturing industry.

2,600 jobs available in midwestern Ontario

Midwestern Ontario sees 2,600 job openings as unemployment rate declines. Manufacturing sector leads hiring surge with opportunities across multiple industries.

Pfizer wins $10B obesity drug takeover battle

Pfizer triumphs in dramatic $10 billion bidding war for obesity drug maker Metsera, securing crucial White House-backed deal to compete in weight-loss market. Read the full story.

Bombardier Partners with U.S. Army for Veteran Careers

Bombardier joins the U.S. Army's Partnership for Your Success (PAYS) program, creating exciting aerospace career opportunities for transitioning soldiers and military veterans across Canada and the United States.

Trump's Plan to Slash Obesity Drug Prices

Former President Donald Trump unveils ambitious strategy to dramatically reduce costs of groundbreaking weight-loss medications, promising relief for millions struggling with obesity.

Trump's Drug Price Plan Backfires, Helps Democrats

Former President Trump's proposal to regulate Medicare drug prices faces unexpected consequences as Democrats leverage it to attack Republican positions on healthcare, creating political turmoil.

Trump Obesity Drug Deal Boosts Pharma Stocks

Major pharmaceutical giants Novo Nordisk and Eli Lilly experience significant stock surges as former President Donald Trump considers a groundbreaking obesity drug partnership, potentially revolutionizing weight loss treatment accessibility.

Chocolate Profits Melt Under Cocoa Price Surge

Global chocolate giant Barry Callebaut reports significant profit decline as cocoa prices reach unprecedented highs, forcing industry-wide price adjustments and innovation.

U.S. Steel Plans $1.1B Investment Through 2028

U.S. Steel announces transformative $1.1 billion capital investment strategy across all business segments, focusing on modernization and operational excellence through 2028.

Canadian Toques: Stitching National Pride

Discover the heartwarming story behind Canadian-made toques and how these humble winter hats evolved into powerful symbols of national identity and economic resilience.

Pharma Veteran Dr. Andreas Wallnofer Joins Optigo Board

Optigo Biotherapeutics strengthens leadership with renowned pharmaceutical expert Dr. Andreas Wallnofer joining its Board of Directors as the company progresses toward Investigational New Drug (IND) enabling studies.

Zekelman Pays Canadians to Report Foreign Steel

Canadian steel manufacturer Zekelman Industries is offering financial incentives to Canadians who report unauthorized foreign steel being used in domestic construction projects, aiming to protect local jobs and industry standards.

NextStar Energy Pivots to Energy Storage in Windsor

NextStar Energy is shifting gears at its Windsor, Ontario plant to manufacture energy storage batteries, adapting to the slowing electric vehicle market while maintaining its commitment to clean energy technology.

Page 3 of 4